CollPlant Biotechnologies... (CLGN)
NASDAQ: CLGN
· Real-Time Price · USD
2.40
-0.06 (-2.44%)
At close: Oct 03, 2025, 3:58 PM
2.34
-2.50%
After-hours: Oct 03, 2025, 07:21 PM EDT
CollPlant Biotechnologies Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 11.71M | 10.73M | 11.91M | 15.37M | 18.92M | 23.46M | 26.91M | 28.98M | 22.28M | 26.53M | 29.65M | 32.81M | 36.29M | 41.07M | 13.15M | 25.75M | 17.48M | 19.72M |
Short-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 30.15M | 20.1M | 30.07M | 30.02M |
Long-Term Investments | 130K | n/a | n/a | n/a | n/a | 57K | 57K | 54K | 237K | 240K | 188K | 187K | 189K | 208K | 213K | 205K | 178K | 174K |
Other Long-Term Assets | n/a | 117K | 118K | 115K | 113K | 57K | 57K | 54K | 237K | 240K | 188K | 187K | 189K | 208K | 213K | 205K | 178K | 174K |
Receivables | n/a | 440K | 583K | 431K | 250K | 369K | 393K | 497K | 10.92M | 731K | 552K | 498K | 603K | 263K | 694K | 878K | 1.26M | 441K |
Inventory | 553K | 673K | 440K | 454K | 439K | 645K | 714K | 1.5M | 1.55M | 1.78M | 1.43M | 1.13M | 1.36M | 1.27M | 1.08M | 1.15M | 940K | 1.27M |
Other Current Assets | 364K | 245K | 248K | 241K | 726K | 518K | 241K | 719K | 863K | 430K | 566K | 512K | 617K | 13K | 437K | 756K | 991K | 279K |
Total Current Assets | 12.62M | 12.09M | 13.18M | 16.5M | 20.34M | 24.48M | 28.02M | 31.21M | 34.86M | 29.06M | 31.66M | 34.46M | 38.27M | 42.62M | 45.09M | 47.9M | 49.77M | 51.47M |
Property-Plant & Equipment | 4.58M | 4.88M | 5.28M | 5.68M | 5.96M | 5.58M | 5.86M | 6.09M | 6.26M | 6.22M | 5.68M | 5.67M | 5.72M | 5.66M | 5.68M | 5.33M | 4.91M | 4.85M |
Goodwill & Intangibles | 102K | 116K | 131K | 145K | 159K | 173K | 188K | 202K | 216K | 231K | 245K | 238K | 235K | 239K | 243K | 194K | 164K | 138K |
Total Long-Term Assets | 4.81M | 5.12M | 5.53M | 5.95M | 6.23M | 5.82M | 6.1M | 6.35M | 6.71M | 6.7M | 6.11M | 6.1M | 6.14M | 6.11M | 6.14M | 5.73M | 5.25M | 5.17M |
Total Assets | 17.44M | 17.21M | 18.71M | 22.44M | 26.57M | 30.29M | 34.13M | 37.56M | 41.57M | 35.76M | 37.77M | 40.56M | 44.41M | 48.72M | 51.22M | 53.63M | 55.02M | 56.63M |
Account Payables | 571K | 770K | 870K | 1.01M | 1.14M | 1.12M | 980K | 744K | 763K | 885K | 1.13M | 880K | 760K | 1M | 1.03M | 865K | 698K | 894K |
Deferred Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 32K | n/a | n/a | 164K |
Short-Term Debt | 837K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Liabilities | 1.33M | n/a | 1.19M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 93K | n/a | n/a | n/a |
Total Current Liabilities | 2.74M | 2.7M | 2.97M | 3.07M | 3.24M | 3.42M | 3.25M | 2.63M | 2.78M | 2.92M | 3.1M | 2.33M | 2.36M | 2.61M | 3.01M | 2.52M | 2.93M | 3.38M |
Long-Term Debt | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Liabilities | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Liabilities | 2.19M | 2.11M | 2.27M | 2.46M | 2.6M | 2.42M | 2.54M | 2.53M | 2.75M | 2.95M | 2.38M | 2.42M | 2.55M | 2.92M | 3.09M | 2.64M | 2.65M | 2.61M |
Total Liabilities | 4.93M | 4.81M | 5.25M | 5.52M | 5.84M | 5.85M | 5.79M | 5.16M | 5.53M | 5.87M | 5.49M | 4.75M | 4.91M | 5.53M | 6.1M | 5.15M | 5.58M | 5.99M |
Total Debt | 3.03M | 2.84M | 3.08M | 3.25M | 3.38M | 3.02M | 3.16M | 3.1M | 3.35M | 3.48M | 2.91M | 2.9M | 3.02M | 3.43M | 3.61M | 3.33M | 3.3M | 3.26M |
Book Value | 12.51M | 12.4M | 13.46M | 16.92M | 20.73M | 24.45M | 28.34M | 32.4M | 36.04M | 29.89M | 32.28M | 35.81M | 39.51M | 43.2M | 45.12M | 48.48M | 49.44M | 50.65M |
Book Value Per Share | 1.06 | 1.08 | 1.18 | 1.48 | 1.81 | 2.13 | 2.47 | 2.83 | 3.17 | 2.65 | 2.89 | 3.23 | 3.56 | 4.01 | 4.21 | 4.62 | 4.85 | 6.02 |
Common Stock | 5.49M | 4.98M | 4.98M | 4.98M | 4.98M | 4.98M | 4.98M | 4.98M | 4.96M | 4.96M | 4.87M | 4.83M | 4.83M | 4.83M | 4.66M | 4.65M | 4.45M | 4.29M |
Retained Earnings | -118.15M | -114.8M | -113.35M | -109.47M | -105.15M | -100.94M | -96.74M | -92.05M | -87.67M | -93.44M | -89.72M | -85.32M | -80.94M | -76.66M | -72.8M | -69.03M | -65.95M | -62.91M |
Comprehensive Income | -969K | -969K | -969K | -969K | -969K | -969K | -969K | -969K | -969K | -969K | -969K | -969K | -969K | -969K | -969K | -969K | -969K | -969K |
Shareholders Equity | 12.51M | 12.4M | 13.46M | 16.92M | 20.73M | 24.45M | 28.34M | 32.4M | 36.04M | 29.89M | 32.28M | 35.81M | 39.51M | 43.2M | 45.12M | 48.48M | 49.44M | 50.65M |
Total Investments | 130K | n/a | n/a | n/a | 113K | 57K | 57K | 54K | 237K | 240K | 188K | 187K | 189K | 208K | 30.15M | 20.1M | 30.07M | 30.02M |